GAVS Technologies is pleased to announce the opening of its offices in Bengaluru and Hyderabad, India. It is a key milestone for GAVS as it expands its footprint within India.
The two new offices will function as development centres as GAVS continues to support its global clients and enable them to achieve their business imperatives.
“This is very aspirational for us. Largely because this is going to be a conduit to truly build a healthcare technology company.” – Sumit Ganguli, CEO, GAVS Technologies
GAVS continues to focus on building competency in the healthcare domain. It is committed to leverage technologies such as AI, ML, Blockchain to develop solutions and emerge as true partners for its clients.
About GAVS Technologies
GAVS Technologies (GAVS) is a global IT services provider with a focus on AI-led Managed Services and Digital Transformation. GAVS’ AIOps platform, Zero Incident FrameworkTM (ZIFTM), enables proactive detection and remediation of incidents and increases uptime, helping organizations drive towards a Zero Incident EnterpriseTM. ZIFTM, an on-premise, and SaaS solution, enable IT to deliver high-performing systems with end-to-end visibility that helps manage and optimize resources and assets and drives value for businesses. GAVS has transformed IT Enterprise delivery through ZIFTM’s Discover, Monitor, Analyze, Predict, and Remediate modules, to optimize IT infrastructure performance, prevent data disasters and enhance business services continuity.
116 Village Boulevard,
Princeton, NJ 08540
Release ID: 19128
The above review statements are those of the sponsor (Source of content) and do not necessarily reflect the official policy, position or views of the content publisher. The content distribution company is therefore not responsible for the content and its authenticity and legal standing of the above subject matter. Each individual is required to exercise its content when making a purchase from the above offer. The information does not constitute advice or an offer to buy. Any purchase made from the above press release is made at your own risk. Editorial merit of this content is subject to news publisher and its downstream partners. Consult an expert advisor/health and professional advisor before any such purchase. Any purchase made from this link is subject to the final terms and conditions of the website’s selling as mentioned in the above as source. The content publisher and its downstream distribution partners do not take any responsibility directly or indirectly. If you have any complaints or copyright issues related to this article, kindly contact the company this news is about.
DISCLAIMER of Liability. IN NO EVENT SHALL OUR PR COMPANY BE LIABLE OR RESPONSIBLE TO YOU OR ANY OTHER PERSON FOR ANY DIRECT, INDIRECT, INCIDENTAL, CONSEQUENTIAL, SPECIAL, OR EXEMPLARY DAMAGES OF ANY KIND, INCLUDING WITHOUT LIMITATION, LOST PROFITS OR LOST OPPORTUNITIES, EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGES IN ADVANCE AND REGARDLESS OF THE CAUSE OF ACTION UPON WHICH ANY SUCH CLAIM IS BASED, INCLUDING, WITHOUT LIMITATION, ANY CLAIM ARISING OUT OF OR IN CONNECTION WITH ANY OF THE CONTENT, INCLUDING, WITHOUT LIMITATION, AUDIO, PHOTOGRAPHS, AND VIDEOS, OR OF THE ACCURACY, RELIABILITY, OR LEGALITY OF ANY STATEMENT MADE IN OR OMITTED FROM ANY advertisement, sponsorship, endorsement, testimonial, opinion, or other product-related or service-related statement or review appearing in the Websites or in ANY post or article distributed via the Websites.